Company Page

Changed Risks for AKORN INC (AKRX)

Sales of our products may be adversely affected by further consolidation of our customer base, which may have a material adverse effect on our business, financial position and results of operations

The issuance of shares related to the Company’s various stock plans may have a substantial dilutive effect on our common stock

We may not be able to extend or replace the JPM Revolving Facility

Business interruptions at our manufacturing facilities can have a material adverse effect on our business, financial position and results of operations

There are material uncertainties and risks associated with damage claims from the Fresenius parties' and Akorn's shareholders as a result of the termination of the April 2017 Merger Agreement

We are subject to extensive government regulations When regulations change or we fall out of compliance, we can face increased costs, additional obligations, fines, or halts to our operations

Changes in healthcare law and policy may adversely affect our business and results of operations

We are involved in legal proceedings and governmental investigations from time to time, any of which may result in substantial losses, government enforcement actions, damage to our business and reputation and place a strain on our internal resources

We may need to obtain additional capital to grow our business, which could restrict our ability to operate in a manner we deem to be in our best interest

Events of default may occur under our debt instruments If events of default occur and lenders under these debt instruments accelerate the obligations thereunder we may not be able to repay the obligations that become immediately due and the holders of our debt instruments may seek to assert their rights under the debt instruments

We depend on our employees and must continue to attract and retain key personnel in order to be successful, and failure to do so hinders successful execution of our business and development plans